This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jiulin Wang: Innovator in Pharmaceutical Composition
Introduction
Jiulin Wang is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.
Latest Patents
Jiulin Wang holds a patent for a composition comprising aflibercept and a variant thereof. This invention includes a truncation variant with a truncated VEGF binding portion of aflibercept, where the content of the truncation variant is less than or equal to about 20% by mass percentage. Additionally, the patent outlines a pharmaceutical formulation that incorporates this composition. It also provides methods for detecting the variant and its use in quality inspection or quality control of aflibercept-containing products.
Career Highlights
Jiulin Wang is associated with Qilu Pharmaceutical Co., Ltd., a prominent company in the pharmaceutical industry. His work focuses on advancing drug formulations and improving the quality of pharmaceutical products.
Collaborations
Jiulin Wang collaborates with esteemed colleagues, including Yue Yu and Guijiang Wang, to further enhance the research and development efforts within his field.
Conclusion
Jiulin Wang's innovative work in pharmaceutical compositions demonstrates his commitment to improving healthcare solutions. His contributions are vital in the ongoing quest for effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile